Use of AI Can Help Identify Coronary Thin-Cap Fibroatheromas
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 2, 2025 -- An artificial intelligence (AI)-based image analysis can identify coronary thin-cap fibroatheromas (TCFAs), which are associated with adverse cardiovascular outcomes, according to a study published online Sept. 1 in the European Heart Journal.
Rick H.J.A. Volleberg, M.D., from Radboud University Medical Center in the Netherlands, and colleagues conducted a secondary analysis of a prospective observational study in which 438 patients with myocardial infarction underwent optical coherence tomography (OCT) of all fractional flow reserve-negative nonculprit lesions (target lesions). OCT images were analyzed for the presence of TCFA by an independent core laboratory (CL-TCFA) and a recently developed and validated AI segmentation algorithm (AI-TCFA).
Overall, AI-TCFA and CL-TCFA were identified in 34.5 and 30.0 percent, respectively, of the 414 patients. The researchers observed a significant association for AI-TCFA within the target lesion with the primary outcome (defined as the composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization at two years; hazard ratio, 1.99; 95 percent confidence interval, 1.02 to 3.90; P = 0.04); the hazard ratio for CL-TCFA was not significant (1.67; 95 percent confidence interval, 0.84 to 3.30; P = 0.14). AI-TCFA showed a stronger association with the primary outcome when evaluating the complete pullback (hazard ratio, 5.50; 95 percent confidence interval, 1.94 to 15.62; P < 0.001).
"Thanks to our AI, we are now a step closer to scanning entire coronary arteries for vulnerable spots in clinical practice," coauthor Jos Thannhauser, Ph.D., also from Radboud University Medical Center, said in a statement. "I do expect, however, that it will take a number of years before this becomes reality."
Several authors disclosed ties to the medical technology and imaging industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2025
Read this next
Spironolactone Does Not Reduce Risk for Cardiovascular Morbidity, Mortality in Patients on Dialysis
THURSDAY, Aug. 28, 2025 -- Spironolactone does not reduce a composite outcome of cardiovascular mortality and hospitalization due to heart failure among patients receiving...
Shared, Sex-Specific Body Fat Patterns Linked to Cardiovascular Aging
WEDNESDAY, Aug. 27, 2025 -- Shared and sex-specific patterns of body fat are associated with changes in cardiovascular aging, according to a study published online Aug. 22 in the...
Seniors With Certain Cardiovascular Diseases Saw Life's Essential 8 Scores Decline 2013 to 2018
WEDNESDAY, Aug. 20, 2025 -- From 2013 to 2018, older adults with heart failure, stroke, and hypertension experienced significant declines in Life's Essential 8 (LE8) scores...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.